My prediction was a bit more conservative only because infected burns don't have the same scope and potential as sepsis or sinusitis. I think those results will really get her rocketing.
Having said that I was pondering the other day why they might have chosen burns as one of their original targets and I think it could be a stroke of genius. Having a drug be safe to ingest or take intravenous is a much more considerable challenge, but topical is much easier/safer. could it be they chose burns as a safe backstop for the company/drug/stock?
RCE price prediction 2 weeks after burns results., page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.030(6.74%) |
Mkt cap ! $120.0M | |||
| Open | High | Low | Value | Volume |
| 44.0¢ | 44.0¢ | 41.5¢ | $43.60K | 102.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4761 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 5045 | 1 |
View Market Depth
| Last trade - 13.33pm 28/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |